Jamieson has advised the management team of Kinapse, a leading global provider of advisory, capability building and operational services to the life sciences industries, on its sale to funds backed by HgCapital. HgCapital will back the existing management and assume majority ownership from management shareholders and Synova Capital.
Established ten years ago by Co-Founders Nicholas Edwards, Chairman, and Andy Black, CEO, Kinapse provides advisory, capability building and operational services to the world’s leading life sciences organisations, their customers, suppliers and regulators. The Group has offices in the UK, India and the United States and employs over 500 professionals worldwide. Kinapse is a partner of 9 out of the top 10 global pharma companies.
Kinapse has grown significantly in recent years and has featured on the Sunday Times Fast Track 100 list of the fastest growing companies in the UK for three consecutive years. It recently opened US offices in Chicago, Cambridge and Manhattan and expanded operations and teams in India.
”I’d like to express my sincere thanks to Tom Burton and David Kirkpatrick who did a great job in an intense period working with us. I believe their extensive experience of private equity transactions combined with the effective way they engaged all parties was essential in enabling us to achieve a successful outcome.”
Andy Black, CEO
The Jamieson team, led by Tom Burton and David Kirkpatrick, advised Andy Black and his management team on the terms of the new deal, as well as providing assistance with executing the transaction once terms had been agreed between all parties.
